Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Singapore Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20202
20213
20231
20246
202511
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
AstraZeneca2
National University Hospital, Singapore2
AbbVie1
Amgen1
ArriVent BioPharma, Inc.1
Bayer1
BlossomHill Therapeutics1
Boehringer Ingelheim1
ETOP IBCSG Partners Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung29
Lung Neoplasms11
Bronchial Neoplasms3
Carcinoma3
Head and Neck Neoplasms3
Lung Diseases3
Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Breast Neoplasms2
Carcinoma, Squamous Cell2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.